ZANINOTTO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.982
AS - Asia 6.501
EU - Europa 2.846
AF - Africa 1.183
SA - Sud America 1.072
Continente sconosciuto - Info sul continente non disponibili 129
OC - Oceania 126
Totale 25.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.369
SG - Singapore 1.977
CN - Cina 1.121
VN - Vietnam 863
HK - Hong Kong 749
BR - Brasile 606
IT - Italia 325
FI - Finlandia 290
FR - Francia 276
BD - Bangladesh 255
DE - Germania 236
SE - Svezia 201
UA - Ucraina 189
IN - India 185
GB - Regno Unito 134
RU - Federazione Russa 117
IQ - Iraq 113
PL - Polonia 101
AR - Argentina 85
JP - Giappone 85
NL - Olanda 83
PH - Filippine 83
PK - Pakistan 78
TR - Turchia 76
SA - Arabia Saudita 72
AT - Austria 65
CA - Canada 65
ID - Indonesia 65
UZ - Uzbekistan 65
ZA - Sudafrica 64
MX - Messico 57
ES - Italia 56
VE - Venezuela 55
CL - Cile 53
IE - Irlanda 52
AL - Albania 49
ET - Etiopia 48
EC - Ecuador 45
BJ - Benin 44
AO - Angola 43
CO - Colombia 43
PY - Paraguay 42
GM - Gambi 41
KE - Kenya 41
SN - Senegal 41
TN - Tunisia 41
UY - Uruguay 41
CZ - Repubblica Ceca 40
MA - Marocco 39
AE - Emirati Arabi Uniti 38
BO - Bolivia 38
JM - Giamaica 38
MY - Malesia 37
PA - Panama 37
TH - Thailandia 37
AZ - Azerbaigian 36
CI - Costa d'Avorio 36
GR - Grecia 36
JO - Giordania 36
KR - Corea 36
YE - Yemen 36
BZ - Belize 35
DO - Repubblica Dominicana 35
HN - Honduras 34
PE - Perù 34
RS - Serbia 34
BY - Bielorussia 32
CH - Svizzera 32
CR - Costa Rica 32
CU - Cuba 32
EG - Egitto 32
TJ - Tagikistan 32
AU - Australia 31
BG - Bulgaria 31
HR - Croazia 31
LA - Repubblica Popolare Democratica del Laos 31
PT - Portogallo 31
SK - Slovacchia (Repubblica Slovacca) 31
HU - Ungheria 30
KH - Cambogia 30
ML - Mali 30
MZ - Mozambico 30
SO - Somalia 30
UG - Uganda 30
XK - ???statistics.table.value.countryCode.XK??? 30
GE - Georgia 29
IR - Iran 29
MW - Malawi 29
NZ - Nuova Zelanda 29
ZW - Zimbabwe 29
CW - ???statistics.table.value.countryCode.CW??? 28
HT - Haiti 28
IL - Israele 28
ME - Montenegro 28
NP - Nepal 28
RW - Ruanda 28
DK - Danimarca 27
DZ - Algeria 27
GF - Guiana Francese 27
LU - Lussemburgo 27
Totale 24.486
Salva come PNG Salva come JPEG
Città #
Fairfield 1.700
Ashburn 1.401
Singapore 1.193
San Jose 1.073
Woodbridge 997
Houston 844
Jacksonville 728
Hong Kong 670
Chandler 655
Seattle 632
Wilmington 627
Cambridge 571
Ann Arbor 528
Princeton 277
Santa Clara 258
Los Angeles 244
Ho Chi Minh City 240
Hanoi 217
Boardman 208
Beijing 203
San Diego 182
Lauterbourg 134
Helsinki 127
New York 102
Roxbury 101
Nanjing 93
Des Moines 79
Chicago 64
The Dalles 61
Tashkent 57
Guangzhou 56
Dong Ket 55
Buffalo 53
Bytom 52
Tokyo 52
Baghdad 50
Medford 49
São Paulo 49
Dublin 48
Orem 43
Shenyang 43
Vienna 42
Padova 41
Dakar 40
Cotonou 39
Luanda 38
Addis Ababa 37
Abidjan 34
Munich 34
Council Bluffs 33
Haiphong 33
Montevideo 33
Nairobi 33
Amman 32
Panama City 32
Baku 31
Da Nang 31
Dushanbe 30
Havana 30
Jeddah 30
Bamako 29
Johannesburg 29
Kampala 29
Milan 29
Warsaw 29
Kigali 28
London 27
Nanchang 27
Ulan Bator 27
Atlanta 26
Dallas 26
Harare 26
Hebei 25
Istanbul 25
Lusaka 25
Managua 25
Phnom Penh 25
Podgorica 25
Tirana 25
Vientiane 25
Willemstad 25
Nassau 24
Tbilisi 24
Castries 23
Maputo 23
Minsk 23
Noumea 23
Nuremberg 23
San José 23
Antananarivo 22
Cayenne 22
Kingston 22
Libreville 22
Norwalk 22
Rome 22
Bishkek 21
Bridgetown 21
Cape Town 21
Conakry 21
Frankfurt am Main 21
Totale 16.449
Salva come PNG Salva come JPEG
Nome #
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 355
Minimally invasive enucleation of esophageal leiomyoma 326
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 313
Toll-like Receptor 2 Regulates Intestinal Inflammation by Controlling Integrity of the Enteric Nervous System 281
ALTERED ESOPHAGEAL PAIN THRESHOLD IN IRRITABLE-BOWEL-SYNDROME 277
MicroRNA expression profiling in human Barrett's carcinogenesis. 276
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation. 269
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia 267
Shorter myotomy on the gastric site (≤2.5 cm) provides adequate relief of dysphagia in achalasia patients 265
CDX2 hox gene product in a rat model of esophageal cancer 254
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 253
Aurora kinase A in Barrett's carcinogenesis. 253
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. 251
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 250
Diffuse esophageal spasm: the surgical approach 247
Herpes simplex Virus type 1 Infection of the Rat Enteric Nervous System Evokes Small Bowel Neuromuscular Abnormalities. 246
The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. 242
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 241
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 240
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma 237
Laparoscopic Heller myotomy can be used as primary therapy for esophageal achalasia regardless of age 236
Programmed cell death 4 protein in esophageal cancer 234
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 232
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 228
Mediastinal carcinosis involving the esophagus in breast cancer: the"breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis andtreatment. 226
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis 225
Oesophageal resection for high-grade dysplasia in Barrett's oesophagus 222
Barrett's epithelium after antireflux surgery 221
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 220
Only Pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery Alone 217
Radiological evidence of subclinical dysphagia in motor neuron disease 216
Esophageal achalasia: Is the herpes simplex virus really innocent? 214
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 213
Altered Intestinal Motility Following Enteric Nervous System Infection by Herpes Simplex Virus Type 1 is Related to Gut Neuroanatomical and Neurochemical Abnormalities 212
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. 212
The 2018 ISDE Achalasia guidelines 209
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. 205
Esophageal motor function in patients with myotonic dystrophy 204
T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens 202
SEQUENTIAL INTRALUMINAL ENDOSCOPIC AND LAPAROSCOPIC TREATMENT FOR BILE DUCT STONES ASSOCIATED WITH GALLSTONES. 200
Therapeutic Strategies for Epiphrenic Diverticula: Systematic Review 199
Laparoscopic Re-Do Myotomy for Recurrent Achalasia After Heller-Dor Procedure 199
MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options. 199
Long-term results (6-10 years) of laparoscopic fundoplication 199
Barrett's epithelium after antireflux surgery 199
Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. 197
Altered intestinal motility following enteric nervous system infection by Herpes Simplex Virus 1 195
Laparoscopic Repair of Epiphrenic Diverticulum 195
Long-term outcome of operated and unoperated epiphrenic diverticula 194
Long-term outcome and risk of oesophageal cancer after surgery for achalasia. 194
Zenker's Diverticula: Feasibility of a Tailored Approach Based on Diverticulum Size 193
Achalasia: Pneumatic Dilation or Laparoscopic Heller Myotomy? 193
Role of Toll-Like receptor 2 in intestinal immune response and dysfunction induced by herpes symplex virus type 1 infection of murine enteric nervous system 193
Erosion of an esophageal endoprosthesis into the trachea 190
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. 189
The short esophagus: Intraoperative assessment of esophageal length 186
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. 181
Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia 181
Laparoscopic live donor nephrectomy: Single center experience 180
TOLL-LIKE RECEPTOR 2 INFLUENCES THE SEVERITY OF NEUROPATHY DURING HERPES SIMPLEX VIRUS TYPE 1 INFECTION OF MURINE ENTERIC NERVOUS SYSTEM 178
Endoscopic and surgical management of achalasia 176
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia 176
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 175
Oesophageal diverticula 175
Surgical management of refractory gastro-oesophageal reflux 174
Chylothorax complicating esophagectomy for cancer: A plea for early thoracic duct ligation 174
Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis 174
Economic evaluation of the randomized European Achalasia trial comparing pneumodilation with Laparoscopic Heller myotomy 174
Etiology, diagnosis and treatment of failures after laparoscopic Heller Myotomy for achalasia 173
Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation 173
LAPAROSCOPIC VERSUS CONVENTIONAL SURGERY FOR SUSPECTED APPENDICITIS IN WOMEN 173
Objective follow-up after laparoscopic repair of large type III hiatal hernia. Assessment of safety and durability 172
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia 171
ONE YEAR FOLLOW-UP AFTER LAPAROSCOPIC HELLER-DOR OPERATION FOR ESOPHAGEAL ACHALASIA 168
DNA copy number alterations correlate with survival in esophageal adenocarcinoma patients. 168
Outcomes of treatment for achalasia depend on manometric subtype 168
Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial 167
Achalasia and esophago-gastric junction outflow obstruction: focus on the subtypes 167
Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. 164
Barrett's registries in Europe: report of an international workshop 163
Esophageal GIST: Case report of surgical enucleation and update on current a diagnostic and therapeutic options 163
The Myotomy Length on the Gastric Side Doesn't Influence the Final Outcome of Laparoscopic Heller Dor for Esophageal Achalasia 163
Functional and morphological study of the cricopharyngeal muscle in patients with Zenker's diverticulum 162
Surgical options and outcomes in Barrett's esophagus 161
Four Hundred Laparoscopic Myotomies for Esophageal Achalasia A Single Centre Experience 161
The Kagoshima consensus on esophageal achalasia 160
Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: Possible detrimental role of previous endoscopic treatment 160
Esophageal Achalasia in the Veneto Region: Epidemiology and Treatment Epidemiology and Treatment of Achalasia 157
ESOPHAGITIS AND PH OF THE REFLUXATE - EXPERIMENTAL AND CLINICAL-STUDY 156
Gastric precancerous lesion follow up based on pathological evidence 156
Upper esophageal sphincter (UES) myotomy, but not botulinum toxin injection is an effective treatment for severe oropharyngeal dysphagia: Final results of a phase-2 study 156
Pseudoachalasia: not only esophago-gastric cancer 152
Minimally invasive surgery for esophageal achalasia 151
Endoscopic treatment of gastroesophageal reflux disease 150
MAGE, BAGE, and GAGE overexpression in patients with esophageal squamous cell carcinoma and adenocarcinoma of gastric cardia 149
Tailored approach to Zenker's diverticula 149
The Fate of Barrett's Epithelium Under Acid Suppression Obtained by Medical or Surgical Therapy 148
One-year follow-up after laparoscopic Heller-Dor operation for esophageal achalasia 148
Results of esophagectomy for esophageal cancer in elderly patients: Age has little influence on outcome and survival 147
Barrett's Esophagus: Still Much to Learn, But "Yes, We Can!" 146
Totale 20.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.822
article - articoli 72.143
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 945
Totale 147.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.957 0 178 260 140 113 106 81 248 172 37 238 384
2022/20231.310 310 134 28 147 215 187 0 82 163 0 37 7
2023/2024621 46 85 76 43 34 71 25 33 31 28 81 68
2024/20252.531 7 150 117 84 367 85 83 186 256 98 414 684
2025/202611.787 354 963 1.637 1.947 1.012 459 1.539 1.094 1.214 704 437 427
2026/2027493 389 104 0 0 0 0 0 0 0 0 0 0
Totale 25.839